Inflammatory cytokine regulation of TRAIL-mediated apoptosis in thyroid epithelial cells

Cell Death and Differentiation

Volumn 9, Issue 3, 2002, Pages 274-286

  Bretz, J D ^a   Mezosi, E ^a   Giordano, T J ^a   Gauger, P G ^a   Thompson, N W ^a   Baker Jr , J R ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

Apoptosis; Autoimmune disease; Death receptor 5; Decoy receptor; Inflammatory cytokine; Interferon gamma

Indexed keywords

CELL RECEPTOR; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL DEATH; CELL SURFACE; CONTROLLED STUDY; DISEASE COURSE; EPITHELIUM CELL; HASHIMOTO DISEASE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VIVO STUDY; INFLAMMATORY INFILTRATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TARGET ORGAN; THYROID CELL; THYROID GLAND;

APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; EPITHELIAL CELLS; HUMANS; INTERLEUKIN-1; MEMBRANE GLYCOPROTEINS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; THYROID GLAND; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR DECOY RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036124153     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400965     Document Type: Article

References (55)

1. Apoptosis: Mechanisms and roles in pathology
2. Cell death in development
3. Apoptosis and disease: Regulation and clinical relevance of programmed cell death
4. Apoptosis signaling in lymphocytes
5. Apoptosis in the effector phase of autoimmune diabetes, multiple sclerosis and thyroiditis
6. The pathology of the endocrine pancreas in type 1 (insulin-dependent) diabetes mellitus
7. Mouse islet cell lysis mediated by interleukin-1-induced
8. Cell death mediators in autoimmune diabetes-no shortage of suspects
9. The role of Fas in autoimmune diabetes
10. Significant role for fas in the pathogenesis of autoimmune diabetes
11. Potential involvement of Fas and its ligand in the pathogenesis of Hashimoto's thyroiditis
12. Inflammatory cytokine regulation of Fas-mediated apoptosis in thyroid follicular cells
13. Thyroiditis and hepatitis: Fas on the road to disease
14. The role of Fas-mediated apoptosis in thyroid autoimmune disease
15. Apoptosis in thyroid tissue from patients with Hashimoto's thyroiditis
16. Apoptosis in thyroid diseases: A histochemical study
17. Cytokines and thyroid function
18. The effects of a monoclonal antibody to interferon-gamma on experimental autoimmune thyroiditis (EAT): Prevention of disease and decrease of EAT-specific T cells
19. Induction of experimental thyroiditis in mice by recombinant interferon gamma administration
20. T-dependent destruction of thyroid isografts exposed to IFN-gamma
21. Experimental autoimmune thyroiditis (EAT) in mice lacking the IFN-gamma receptor gene
22. Induction of granulomatous experimental autoimmune thyroiditis in mice with in vitro activated effector T cells and anti-IFN-gamma antibody
23. Iodide, cytokines and TSH-receptor expression in Graves' disease
24. Thyroid-stimulating hormone inhibits Fas antigen-mediated apoptosis of human thyrocytes in vitro
25. Possible pathogenetic relevance of interleukin-1 beta in 'destructive' organ-specific autoimmune disease (Hashimoto's thyroiditis)
26. TRAIL death pathway expression and induction in thyroid follicular cells
27. Fas (APO-1, CD95)-mediated apoptosis in thyroid cells is regulated by a labile protein inhibitor
28. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
29. Differential regulation of CD95 (Fas/APO-1) expression in human blood eosinophils
30. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
31. Functional analysis of TRAIL receptors using monoclonal antibodies
32. Expression of TRAIL and its receptors in human brain tumors
33. Molecular determinants of response to TRAIL in killing of normal and cancer cells
34. Apoptotis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
35. Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes
36. Thyroid carcinoma cells are resistant to Fas-mediated apoptosis but sensitive tumor necrosis factor-related apoptosis-inducing ligand
37. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells
38. Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand
39. An antagonist decoy receptor and a death domain-containing receptor for TRAIL
40. A novel receptor for Apo2L/TRAIL contains a truncated death domain
41. Apoptosis control by death and decoy receptors
42. Apoptosis and autoimmunity
43. Autoimmune disease. A problem of defective apoptosis
44. Apoptosis and autoimmune disease
45. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II
46. Rare loss-of-function mutation of a death receptor gene in head and neck cancer
47. Tumor Necrosis Factor-related Apoptosis-inducing Ligand. (TRAIL) is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression
48. Roles of TNF-Related Apoptosis-Inducing Ligand in Experimental Autoimmune Encephalomyelitis
49. Apoptosis and autoimmune thyroid disease: Following the TRAIL to thyroid destruction?
50. FasL expression on epithelial cells: The Bottazzo-Feldman hypothesis revisited
51. Apoptosis induced in normal human hepatocytes by tumor necrosis factor-related apoptosis-inducing ligand
52. Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
53. Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy
54. Flow cytometric analysis of organ preservation-induced endothelial cell membrane damage